Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 106051-106100 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT04107480
PRolaCT - Three Prolactinoma RCTs
PHASE4
Recruiting
880 participants
Started: Jun 21, 2019 · Completed: Mar 31, 2026
2 conditions
1 sponsor
3 locations
NCT03657641
Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer
PHASE1/PHASE2
Active, not recruiting
75 participants
Started: Jun 21, 2019 · Completed: Jun 21, 2026
2 conditions
2 sponsors
3 locations
NCT03299608
Rapid Analysis of Infections by Spectrometry of Exhaled Breath
N/A
Recruiting
246 participants
Started: Jun 21, 2019 · Completed: Sep 30, 2025
2 conditions
1 sponsor
1 location
NCT03812393
Evaluating the Efficacy of Neratinib on Live Cell HER2 Signaling Transduction Analysis Positive Triple Negative Breast
PHASE2
Active, not recruiting
27 participants
Started: Jun 21, 2019 · Completed: Dec 15, 2024
3 conditions
3 sponsors
1 location
NCT04019678
Breast Cancer: Axillary Conservation After Neoadjuvant Chemotherapy in Micro Metastatic Sentinel Lymph Nodes.
NA
Recruiting
850 participants
Started: Jun 21, 2019 · Completed: Jun 21, 2027
1 condition
1 sponsor
1 location
NCT03996239
Researching the Effect of Aerobic Exercise on Cancer
NA
Active, not recruiting
38 participants
Started: Jun 20, 2019 · Completed: Jun 30, 2026
1 condition
3 sponsors
10 locations
NCT03916419
Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer
PHASE2
Active, not recruiting
26 participants
Started: Jun 20, 2019 · Completed: Sep 25, 2025
4 conditions
1 sponsor
1 location
NCT04603196
Prevalence and Impact of Obstructive Sleep Apnea in Multiple Sclerosis
N/A
Recruiting
800 participants
Started: Jun 20, 2019 · Completed: Jun 20, 2030
2 conditions
1 sponsor
1 location
NCT06556888
Observatory of Immunological Thrombopenic Purpura in the Brest Region
N/A
Recruiting
500 participants
Started: Jun 20, 2019 · Completed: Nov 30, 2039
1 condition
1 sponsor
1 location
NCT04009681
A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101)
PHASE1/PHASE2
Active, not recruiting
250 participants
Started: Jun 20, 2019 · Completed: Nov 30, 2025
1 condition
1 sponsor
24 locations
NCT03945448
Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia
PHASE2/PHASE3
Recruiting
356 participants
Started: Jun 20, 2019 · Completed: Apr 30, 2028
1 condition
3 sponsors
1 location
NCT03580109
Spa Therapy for Upper or Lower Limb Lymphoedema
NA
Recruiting
160 participants
Started: Jun 20, 2019 · Completed: Dec 31, 2025
6 conditions
2 sponsors
13 locations
NCT04157049
Alpha-1 Research Registry
N/A
Recruiting
4,000 participants
Started: Jun 20, 2019 · Completed: Jun 20, 2029
1 condition
1 sponsor
1 location
NCT05054335
Patient-Specific Computational Walking Models in Improving Surgical and Rehabilitation Treatment in Patients With Pelvic Sarcomas
NA
Recruiting
130 participants
Started: Jun 20, 2019 · Completed: May 10, 2025
1 condition
2 sponsors
1 location
NCT03187340
Monitored Breathing Awareness Therapy for Insomnia Disorder in Older Adults-2
NA
Active, not recruiting
112 participants
Started: Jun 20, 2019 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT03964233
A Study in Patients With Different Types of Advanced Cancer (Solid Tumors) to Test Different Doses of BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab) and BI 754111 or BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab)
PHASE1
Active, not recruiting
119 participants
Started: Jun 20, 2019 · Completed: May 30, 2026
1 condition
1 sponsor
23 locations
NCT04009343
Pharmacokinetics and Pharmacodynamics of the Gametocytocidal and Post-treatment Chemoprotective Effects of Antimalarials
PHASE2/PHASE3
Active, not recruiting
182 participants
Started: Jun 19, 2019 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT04431609
Carotid Web Associated With Cerebral Infarctions
N/A
Recruiting
300 participants
Started: Jun 19, 2019 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT03965299
Transcutaneous Tibial Nerve Stimulation in Acute Spinal Cord Injury
NA
Recruiting
114 participants
Started: Jun 19, 2019 · Completed: Sep 30, 2026
1 condition
8 sponsors
4 locations
NCT06472804
Insomnia in Patients With Metastatic Lung Cancer
N/A
Recruiting
60 participants
Started: Jun 19, 2019 · Completed: Jun 30, 2026
2 conditions
1 sponsor
1 location
NCT03849417
Brain Imaging Biomarkers of Pathological Brain Aging in Late-life Depression
N/A
Recruiting
128 participants
Started: Jun 19, 2019 · Completed: Dec 31, 2024
1 condition
2 sponsors
1 location
NCT03853486
ATHN 9: Severe VWD Natural History Study
N/A
Active, not recruiting
108 participants
Started: Jun 18, 2019 · Completed: Jul 30, 2026
1 condition
2 sponsors
22 locations
NCT03618381
EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
PHASE1
Recruiting
44 participants
Started: Jun 18, 2019 · Completed: Jun 30, 2040
16 conditions
1 sponsor
1 location
NCT04113863
Evaluation of ATRA Activity in Combination With Anastrozole in Pre-operative Phase of Operable Early Breast Cancer
PHASE2
Recruiting
112 participants
Started: Jun 18, 2019 · Completed: Sep 30, 2024
1 condition
1 sponsor
2 locations
NCT03884660
remedē System Therapy Study
N/A
Active, not recruiting
225 participants
Started: Jun 18, 2019 · Completed: Dec 30, 2030
1 condition
1 sponsor
32 locations
NCT03759938
OPTIMAS: OPtimal TIMing of Anticoagulation After Acute Ischaemic Stroke : a Randomised Controlled Trial
NA
Active, not recruiting
3,648 participants
Started: Jun 18, 2019 · Completed: Oct 31, 2024
2 conditions
1 sponsor
44 locations
NCT03851068
Early Feasibility Study for the Foldax Tria Aortic Heart Valve
NA
Active, not recruiting
40 participants
Started: Jun 18, 2019 · Completed: Dec 31, 2026
2 conditions
1 sponsor
5 locations
NCT05964712
Effects of Therapies in the Acromegaly Disease: Acral Morpho-functional Study
N/A
Recruiting
30 participants
Started: Jun 18, 2019 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT03257969
Impact of the DROP Program on the DRP (Drug Related Problems) Related to Oral Anticancer Drugs in Ambulatory Patients with Risk Factors
NA
Recruiting
248 participants
Started: Jun 18, 2019 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT05701254
Skeletal Effects of Type 1 Diabetes on Low-Trauma Fracture Risk
N/A
Recruiting
80 participants
Started: Jun 18, 2019 · Completed: Jan 31, 2025
4 conditions
1 sponsor
1 location
NCT04126525
Neoadjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer
PHASE2
Active, not recruiting
53 participants
Started: Jun 18, 2019 · Completed: Nov 30, 2026
1 condition
1 sponsor
1 location
NCT03896620
Recognition of Circulating Tumor DNA in Soft Tissue Sarcoma
N/A
Recruiting
50 participants
Started: Jun 18, 2019 · Completed: Jun 1, 2026
1 condition
1 sponsor
1 location
NCT03765307
Bronchial Ablation for Treatment of Asthma (BATA) Trial
NA
Active, not recruiting
160 participants
Started: Jun 18, 2019 · Completed: Dec 31, 2028
1 condition
2 sponsors
15 locations
NCT05888636
Transcriptomics and Epigenetics Analysis in Drug-Resistance of Multiple Myeloma
N/A
Recruiting
200 participants
Started: Jun 18, 2019 · Completed: Dec 31, 2024
1 condition
4 sponsors
2 locations
NCT05049538
Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers
N/A
Recruiting
1,000 participants
Started: Jun 18, 2019 · Completed: Jun 30, 2028
6 conditions
1 sponsor
1 location
NCT03888924
Bacille Calmette-Guérin (BCG) Vaccine In Radiologically Isolated Syndrome (RIS)
PHASE2
Recruiting
100 participants
Started: Jun 17, 2019 · Completed: Oct 1, 2026
1 condition
1 sponsor
1 location
NCT03946527
LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA)
PHASE2
Active, not recruiting
10 participants
Started: Jun 17, 2019 · Completed: Mar 31, 2026
2 conditions
2 sponsors
2 locations
NCT03604978
Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma
PHASE1/PHASE2
Active, not recruiting
38 participants
Started: Jun 17, 2019 · Completed: Nov 30, 2025
3 conditions
1 sponsor
29 locations
NCT04057638
Craniomaxillofacial and Upper Extremity Allotransplantation
NA
Recruiting
10 participants
Started: Jun 17, 2019 · Completed: Jan 1, 2026
6 conditions
1 sponsor
1 location
NCT03840395
The PhINEST Study - Pharyngeal ICU Novel Electrical Stimulation Therapy
NA
Recruiting
360 participants
Started: Jun 17, 2019 · Completed: Dec 31, 2025
1 condition
3 sponsors
7 locations
NCT03943875
GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose
PHASE4
Active, not recruiting
757 participants
Started: Jun 17, 2019 · Completed: Mar 1, 2026
3 conditions
2 sponsors
1 location
NCT03944941
Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer
PHASE2
Active, not recruiting
60 participants
Started: Jun 17, 2019 · Completed: Dec 1, 2028
2 conditions
2 sponsors
428 locations
NCT04040920
Ozone Application Before Fissure Sealants
NA
Recruiting
67 participants
Started: Jun 17, 2019 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT03728985
Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms
NA
Active, not recruiting
102 participants
Started: Jun 17, 2019 · Completed: Sep 30, 2026
1 condition
1 sponsor
44 locations
NCT04182412
Abdominal Rectus Diastasis (ARD) Reconstruction
NA
Recruiting
110 participants
Started: Jun 17, 2019 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT03829254
A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma
PHASE1/PHASE2
Recruiting
135 participants
Started: Jun 17, 2019 · Completed: Aug 31, 2026
4 conditions
1 sponsor
9 locations
NCT03659448
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
PHASE3
Recruiting
300 participants
Started: Jun 17, 2019 · Completed: Dec 31, 2024
1 condition
1 sponsor
11 locations
NCT04024631
Phenotyping Genetic Risk for Type 2 Diabetes
NA
Recruiting
100 participants
Started: Jun 17, 2019 · Completed: Jun 30, 2026
2 conditions
1 sponsor
2 locations
NCT03895437
Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients
PHASE2
Active, not recruiting
78 participants
Started: Jun 17, 2019 · Completed: Sep 30, 2023
1 condition
1 sponsor
23 locations
NCT04171830
Clinical Surveillance Tool to Screen for Unmet Palliative Needs Among Patients in the Final Year of Life
NA
Enrolling by invitation
3,536 participants
Started: Jun 17, 2019 · Completed: Mar 31, 2024
4 conditions
23 sponsors
13 locations
Previous
1
More pages
2119
2120
2121
2122
2123
2124
2125
More pages
2369
Next